JGC
AUXL

J. Goldman & Co’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

J. Goldman & Co’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-161,500
Closed -$2.94M – 349
2013
Q3 		$2.94M Buy
+161,500
New +$2.92M 0.28% 123

Other funds holding AUXL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

J. Goldman & Co's AUXL Position: Q4 2014 in Review

J. Goldman & Co sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 87,860 shares — an estimated $2.62M sold.

J. Goldman & Co first reported a position in AUXL in Q2 2013 and held it in 4 quarters. The position peaked at $2.62M in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • J. Goldman & Co reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • J. Goldman & Co sold 87,860 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $2.62M.
  • J. Goldman & Co first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • J. Goldman & Co's AUXILIUM PHARAMCEUTICALS INC position peaked at $2.62M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on J. Goldman & Co's 13F filing for Q4 2014, filed 17 Feb 2015.